Baltimore-Washington Financial Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Hold
0
120
2020
Q3
Sell
-13,514
Closed -$17K 120
2020
Q2
$17K Buy
+13,514
New +$851K ﹤0.01% 127
2017
Q3
Sell
-62,540
Closed -$5.03M 76
2017
Q2
$5.03M Buy
62,540
+5,526
+10% +$436K 1.21% 46
2017
Q1
$4.48M Buy
57,014
+13,716
+32% +$1.1M 1.14% 46
2016
Q4
$3.42M Sell
43,298
-10,505
-20% -$850K 0.94% 52
2016
Q3
$4.79M Buy
+53,803
New +$5.08M 1.36% 38
2015
Q4
Sell
-73
Closed -$7K 120
2015
Q3
$7K Hold
73
﹤0.01% 217
2015
Q2
$7K Sell
73
-468
-87% -$47.8K ﹤0.01% 190
2015
Q1
$56K Buy
+541
New +$54.7K 0.02% 128
2014
Q3
Sell
-3,000
Closed -$226K 292
2014
Q2
$226K Buy
+3,000
New +$227K 0.07% 105
2014
Q1
Sell
-3,000
Closed -$215K 238
2013
Q4
$215K Buy
+3,000
New +$193K 0.07% 105

Other funds holding CVS

Baltimore-Washington Financial Advisors's CVS Position: Q4 2021 in Review

Baltimore-Washington Financial Advisors held its CVS Health (CVS) position steady in Q4 2021 at 0 shares worth $269K. The position accounts for 0.02% of the portfolio, ranked #120.

Baltimore-Washington Financial Advisors first reported a position in CVS in Q4 2013 and has held it in 10 quarters since. The position peaked at $5.03M in Q2 2017. 2,342 funds tracked by Wall St. Rank hold CVS as of Q4 2021.

  • Baltimore-Washington Financial Advisors held 0 shares of CVS Health worth $269K as of Q4 2021.
  • Baltimore-Washington Financial Advisors left its CVS Health share count unchanged in Q4 2021.
  • CVS Health made up 0.02% of Baltimore-Washington Financial Advisors's portfolio in Q4 2021, its #120 holding.
  • Baltimore-Washington Financial Advisors first reported a position in CVS Health in Q4 2013 and has held it in 10 quarters since.
  • Baltimore-Washington Financial Advisors's CVS Health position peaked at $5.03M in Q2 2017.
  • 2,342 funds tracked by Wall St. Rank held CVS Health as of Q4 2021.

Based on Baltimore-Washington Financial Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.